Floatz logo

txa127

Chronic Myelocytic Leukemia

Tarix PharmaceuticalsPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Chronic Myelocytic Leukemia cohort.

Asset / SponsorPhaseRating
PENTOSTATIN
St. Jude Children's Research Hospital
Phase 3BB
Anti-Thymoglobulin, Rabbit
St. Jude Children's Research Hospital
Phase 2/3BB
Rigosertib
Traws Pharma, Inc.
Phase 1/2B
Angiotensin-(1-7)
Tarix Pharmaceuticals
Phase 1CC

Same molecule, other indications

txa127 is also rated in:

Double Cord Blood TransplantDormant
CC
Indicative ·
43 / 100
View asset →
Non Hodgkins LymphomaDormant
CC
Indicative ·
43 / 100
View asset →
Hodgkins LymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →